Sofinnova Management VIII’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$38M Hold
2017
Q3
$39.7M Hold
2017
Q2
$41.8M Hold
2017
Q1
$45.9M Sell
2016
Q4
$62.1M Buy